Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


23.09.2019

1 J Neuroimmunol
2 J Neurol
2 Mult Scler
1 Nat Rev Neurol
1 Nervenarzt
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Neuroimmunol

  1. KURTUNCU M, Yilmaz V, Akcay HI, Turkoglu R, et al
    Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
    J Neuroimmunol. 2019;337:577065.
    PubMed     Text format     Abstract available


    J Neurol

  2. PAOLICELLI D, Lucisano G, Manni A, Avolio C, et al
    Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.
    J Neurol. 2019 Sep 18. pii: 10.1007/s00415-019-09531.
    PubMed     Text format     Abstract available

  3. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
    J Neurol. 2019 Sep 17. pii: 10.1007/s00415-019-09535.
    PubMed     Text format     Abstract available


    Mult Scler

  4. PALOTAI M, Guttmann CR
    Brain anatomical correlates of fatigue in multiple sclerosis.
    Mult Scler. 2019 Sep 19:1352458519876032. doi: 10.1177/1352458519876032.
    PubMed     Text format     Abstract available

  5. MAGGI P, Absinta M, Sati P, Perrotta G, et al
    The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.
    Mult Scler. 2019 Sep 19:1352458519876031. doi: 10.1177/1352458519876031.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  6. DONG Y, Yong VW
    When encephalitogenic T cells collaborate with microglia in multiple sclerosis.
    Nat Rev Neurol. 2019 Sep 16. pii: 10.1038/s41582-019-0253.
    PubMed     Text format     Abstract available


    Nervenarzt

  7. WINKELMANN A, Lobermann M, Zettl UK
    [Indications for varicella zoster and herpes zoster vaccination in multiple sclerosis: current situation].
    Nervenarzt. 2019 Sep 17. pii: 10.1007/s00115-019-00806.
    PubMed     Text format     Abstract available


    PLoS One

  8. LIN SD, Butler JE, Boswell-Ruys CL, Hoang P, et al
    The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience.
    PLoS One. 2019;14:e0222731.
    PubMed     Text format     Abstract available

  9. MOCCIA M, Tajani A, Acampora R, Signoriello E, et al
    Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.
    PLoS One. 2019;14:e0222012.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: